First Solar (FSLR)
(Delayed Data from NSDQ)
$240.45 USD
-1.36 (-0.56%)
Updated Sep 19, 2024 04:00 PM ET
After-Market: $240.24 -0.21 (-0.09%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth A Momentum A VGM
Price, Consensus and EPS Surprise
FSLR 240.45 -1.36(-0.56%)
Will FSLR be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for FSLR based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for FSLR
First Solar (FSLR) Rises As Market Takes a Dip: Key Facts
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
FSLR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
Enphase Energy Launches IQ Battery 5P and AI-Powered Energy Management
Why First Solar (FSLR) is a Top Value Stock for the Long-Term
Other News for FSLR
Unusually active option classes on open September 19th
First Solar: Nearly The Cheapest It Has Been - Policy Risks Ahead
Unusually active option classes on open September 18th
Jim Cramer Labels Moderna A 'Big Disappointment,' But Suggests Doubling Down On Another Pharma Powerhouse
Unusually active option classes on open September 17th